Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
26.77
-0.38 (-1.40%)
Apr 20, 2026, 1:50 PM EDT - Market open
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $1.17 billion as of April 20, 2026. Its market cap has increased by 282.43% in one year.
Market Cap
1.17B
Enterprise Value
1.18B
1-Year Change
282.43%
Ranking
Category
Stock Price
$26.77
Market Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $1.17B, an increase of 435.40%. That is a compound annual growth rate of 326.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.19B | -9.71% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeMaitre Vascular | 2.61B |
| DENTSPLY SIRONA | 2.50B |
| Pulse Biosciences | 1.59B |
| AtriCure | 1.50B |
| Kestra Medical Technologies | 1.33B |
| STAAR Surgical Company | 1.24B |
| Azenta | 1.15B |
| BioLife Solutions | 1.04B |